Haiqiang Sang

ORCID: 0000-0001-6328-570X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Treatment and Management
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Pancreatic function and diabetes
  • Non-Invasive Vital Sign Monitoring
  • Innovation Policy and R&D
  • Pituitary Gland Disorders and Treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular Health and Disease Prevention
  • Protease and Inhibitor Mechanisms
  • Hemodynamic Monitoring and Therapy
  • Lipid metabolism and disorders
  • Heart Rate Variability and Autonomic Control
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Delphi Technique in Research
  • Sepsis Diagnosis and Treatment
  • Peptidase Inhibition and Analysis
  • Blood Pressure and Hypertension Studies
  • Hormonal Regulation and Hypertension
  • Traditional Chinese Medicine Studies
  • Adrenal and Paraganglionic Tumors
  • Cardiac Imaging and Diagnostics

First Affiliated Hospital of Zhengzhou University
2014-2025

Background Currently, the clinical evidence regarding prognostic significance of TyG index in acute myocardial infarction (AMI) patients remains unclear. Our research analyzed correlation between and risk mortality with AMI, order to evaluate influence on prognosis this population. Methods 1205 ICU AMI were retrospective cohort analysis, necessary data obtained from Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The study conducted Kaplan-Meier analysis compare all-cause...

10.3389/fendo.2025.1447053 article EN cc-by Frontiers in Endocrinology 2025-01-22

Abstract Aims The DELIVER study demonstrates a significant improvement in cardiovascular death or hospitalization for heart failure among with mildly reduced ejection fraction (HFmrEF) preserved (HFpEF).Cost‐utility of the adjunct use dapagliflozin to standard therapy patients HFpEF HFmrEF remains unclear. Methods and results A five‐state Markov mode was constructed project health clinical outcomes 65‐year‐old HFmrEF. cost‐utility analysis performed based on national statistical database....

10.1002/ehf2.14426 article EN cc-by-nc-nd ESC Heart Failure 2023-06-08

Objective: To evaluate the economics and effectiveness of adding dapagliflozin or empagliflozin to standard treatment for heart failure (HF) patients with reduced ejection fraction (HFrEF) in China. Methods: A Markov model was developed project clinical economic outcomes 66-year-old HFrEF. cost-utility analysis performed based mostly on data from outcome trial chronic a (EMPEROR-Reduced) study prevention adverse (DAPA-HF) trial. The primary were measured via total incremental costs...

10.3389/fphar.2021.733681 article EN cc-by Frontiers in Pharmacology 2021-11-11

Aim To determine the pharmacoeconomics of empagliflozin for treatment heart failure (HF) with reduced ejection fraction in China and to provide evidence-based reference clinical rational drug selection medical decision-making. Research design methods We used Markov model evaluate cost-effectiveness HF (HFrEF). evaluated standard addition (empagliflozin group) vs. alone (standard group). Results found that each additional quality-adjusted life year (QALY) group costed $3,842.20 more, which...

10.3389/fcvm.2022.1022020 article EN cc-by Frontiers in Cardiovascular Medicine 2022-11-16

Chromaffin cell-centered pheochromocytoma (Pheo) is a rare tumour. Pheochromocytoma and how it affects the heart will be topic of this article. Due to comparable symptoms indications sympathetic nervous system, might difficult detect early. There are also other frequent differential diagnoses that delay detection pheochromocytoma. One most common side effects unmanageable hypertension. Hypertensive crisis (extreme increases in blood pressure) can develop, which life-threatening condition...

10.1155/2022/3644212 article EN Journal of Oncology 2022-02-11

Objective To investigate the effect of atorvastatin on vascular endothelial function and blood pressure in young middle-aged hypertensive patients without complications.Methods Seventy-four with controlled well complications were randomly divided into study group (37 cases) control cases).Patients both groups received amlodipine,metoprolol treatment,and diet control.In addition,patients also 20 mg atorvastatin.After 8 weeks' treatment,changes pressure,serum nitric oxide (NO),flow-mediated...

10.3760/cma.j.issn.1674-4756.2014.07.013 article EN Central Plains Medical Journal 2014-04-10

Abstract Background Hypertrophic obstructive cardiomyopathy (HOCM) is a serious and complex chronic disease severely affecting patients’ daily lives health-related quality of life (HRQoL). The psychometric performance generic preference-based instruments has not been compared in Chinese patients with HOCM. We aimed to identify an applicable vehicle determine HRQoL explore the properties SF-6Dv2 EQ- 5D-5L adults interchangeability tools cost-utility analysis was also investigated. Methods...

10.1101/2023.10.25.23297528 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2023-10-25
Coming Soon ...